Keshav K. Singh, Ph.D.
Professor of Oncology,
Department of Cancer Genetics
Roswell Park Cancer Institute
Elm and Carlton Streets
Buffalo, NY 14263
Phone: 716-845-8017
Fax: 716-845-1047
Dr. Singh is one of the leaders in the field of mitochondria research and medicine.He is Professor of Oncology at Roswell Park Cancer Institute, the first cancer research, treatment and education center established in the United States. Prior to joining Roswell Park Cancer Institute, he was an Assistant Professor of Oncology and Environmental Health at Johns Hopkins School of Medicine. He is an expert in mitochondrial genetics and has more than 20 years of research experience.

Dr Singh founded the Mitochondria Research Society, is the founding editor-in-chief of the journal Mitochondrion and is instrumental in promoting Mitochondrial Research and Medicine around the world. He has organized scientific meetings and workshops on mitochondria around the world including the Czech Republic, Russia, India and United States. He has also chaired or co-chaired several sessions in international scientific meetings. He is an international advisor to the Asian Society for Mitochondria Research and Medicine, Korea and Mitochondrial Physiology Society, Austria. He serves on the Scientific Advisory Board and the Research Expansion Project of the United Mitochondrial Diseases Foundation. Dr. Singh was awarded a Junior Research Fellowship of Council of Scientific and Industrial Research, India, a Postgraduate Research Award from University of Wollongong, Australia, a Summer Fellowship from Marine Biological Laboratory, Woods Hole, Massachusetts, a Postdoctoral Research Fellowship from American Heart Association, an Individual National Research Service Award from National Cancer Institute, a FIRST Award from National Institute of Environmental Health, National Institute of Health, and a Scientist Development Award from American Heart Association. Dr. Singh serves on the editorial boards of Cancer Biology & Therapy, Technology in Cancer Research and Treatment, Nanomedicine, FEMS Yeast Research and Molecular Cancer. He serves as an expert peer reviewer for several other journals. He is also an expert reviewer of grants submitted to U.S. Department of State, United Mitochondrial Disease Foundation, National Research Council, Canada, Komen Breast Cancer Foundation, and National Institutes of Health. Dr Singh has been quoted in articles on the New Scientist, on the web, (BioMedNet), newspapers, and has given interviews to radio shows and to Associated Press on Mitochondria stories of public interest.

Dr. Singh is the founding member of the American Academy of NanoMedicine. He was appointed as Honorary Chairman of the Business Advisory Council by the Chairman of the National Republican Congressional Committee to help represent issues related to mitochondrial diseases. Dr. Singh is the author of over 50 research publications, two books entitled “Mitochondrial DNA Mutations in Aging, Disease and Cancer” and “Oxidative Stress, Disease and Cancer”. His translational research is aimed at developing methods to identify potential "mitomutagens" present in our environment and agents and methods that can be used in diagnosis and therapy of cancer. His basic research is focused on Mitochondrial oxidative stress, genomic instability and mutagenesis and its role in pathogenesis of mitochondrial diseases, aging and cancer.